Uploaded October 2025 | Updated September 2026, 1 week ago
Noncommunicable dDiseases (NCDs) continue to place immense and growing pressure on health systems worldwide, and traditional financing models are no longer adequate to meet the scale of the challenge. With tightening economic constraints, shifting geopolitical dynamics, and multiple global crises converging, countries must fundamentally rethink how they invest in health, and how these investments translate into comprehensive, integrated NCD prevention and care. Sustained, early, and strategic public investment is essential to ensure better health outcomes for the millions affected and to secure long-term economic resilience.
This World Health Summit 2025 session – co-hosted by Roche – took place just weeks after the UN High-Level Meeting on NCDs (HLM4). It offered a timely opportunity to reflect on the renewed political commitments made in the UN Declaration on NCDs. The discussion was moderated by Shiulie Ghosh (Aero Productions Ltd.). It examined the gaps and opportunities in global and national financing strategies and the need for models that could adapt to rapidly shifting global realities.
The Speakers, Tamara Schudel (Roche), Mohamed Yakub Janabi (WHO Regional Office for Africa), Francesca Colombo (OECD), and Seth Berkley (Pandemic Center, Brown University) explored the strengths and limitations of existing funding mechanisms. They highlighted the potential of innovative financing approaches, including public–private partnerships, blended finance, and impact investment, to advance global NCD targets and support sustainable and equitable care.
The session underscored the need for transformative financing strategies that moved beyond short-term fixes and created long-lasting economic and societal benefits for NCD patients worldwide.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more at www.worldhealthsummit.org.
Noncommunicable dDiseases (NCDs) continue to place immense and growing pressure on health systems worldwide, and traditional financing models are no longer adequate to meet the scale of the challenge. With tightening economic constraints, shifting geopolitical dynamics, and multiple global crises converging, countries must fundamentally rethink how they invest in health, and how these investments translate into comprehensive, integrated NCD prevention and care. Sustained, early, and strategic public investment is essential to ensure better health outcomes for the millions affected and to secure long-term economic resilience.
This World Health Summit 2025 session – co-hosted by Roche – took place just weeks after the UN High-Level Meeting on NCDs (HLM4). It offered a timely opportunity to reflect on the renewed political commitments made in the UN Declaration on NCDs. The discussion was moderated by Shiulie Ghosh (Aero Productions Ltd.). It examined the gaps and opportunities in global and national financing strategies and the need for models that could adapt to rapidly shifting global realities.
The Speakers, Tamara Schudel (Roche), Mohamed Yakub Janabi (WHO Regional Office for Africa), Francesca Colombo (OECD), and Seth Berkley (Pandemic Center, Brown University) explored the strengths and limitations of existing funding mechanisms. They highlighted the potential of innovative financing approaches, including public–private partnerships, blended finance, and impact investment, to advance global NCD targets and support sustainable and equitable care.
The session underscored the need for transformative financing strategies that moved beyond short-term fixes and created long-lasting economic and societal benefits for NCD patients worldwide.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more at www.worldhealthsummit.org.
